7 | Capsaicin (Zostrix)FDA Link
05/2014
-
04/2000 |
5 | Linoleic Acid (Linoleate)IBA
11/2013
-
11/2009 |
4 | Nerve Growth Factor (NGF)IBA
06/2015
-
06/2004 |
4 | LipidsIBA
11/2013
-
11/2009 |
4 | EnzymesIBA
11/2013
-
09/2012 |
4 | Calcitonin Gene-Related PeptideIBA
10/2012
-
11/2003 |
4 | BradykininIBA
07/2011
-
06/2007 |
3 | Cytochrome P-450 Enzyme System (Cytochrome P450)IBA
11/2013
-
09/2012 |
3 | Analgesics (Analgesic Drugs)IBA
11/2013
-
11/2009 |
3 | AntibodiesIBA
11/2013
-
11/2009 |
3 | Transient Receptor Potential ChannelsIBA
09/2011
-
04/2008 |
3 | CannabinoidsIBA
02/2009
-
10/2006 |
3 | Opioid Analgesics (Opioids)IBA
01/2009
-
09/2005 |
2 | CalciumIBA
05/2014
-
10/2012 |
2 | Ketoconazole (Nizoral)FDA LinkGeneric
11/2013
-
09/2012 |
2 | Biological ProductsIBA
03/2013
-
03/2013 |
2 | Serotonin (5 Hydroxytryptamine)IBA
10/2012
-
10/2011 |
2 | Freund's AdjuvantIBA
10/2012
-
09/2012 |
2 | Minocycline (Cyclops)FDA LinkGeneric
06/2012
-
07/2008 |
2 | Ciprofloxacin (Cipro)FDA LinkGeneric
06/2012
-
07/2008 |
2 | Metronidazole (Metric)FDA LinkGeneric
06/2012
-
07/2008 |
2 | D-Penicillamine (2,5)- EnkephalinIBA
02/2012
-
01/2009 |
2 | Adenylyl Cyclases (Adenylyl Cyclase)IBA
02/2012
-
07/2011 |
2 | ProlactinIBA
09/2011
-
02/2010 |
2 | NeuropeptidesIBA
08/2011
-
06/2004 |
2 | Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
02/2011
-
01/2005 |
2 | Estrogen ReceptorsIBA
10/2010
-
04/2009 |
2 | Local AnestheticsIBA
07/2010
-
07/2007 |
2 | Arachidonic Acid (Vitamin F)IBA
01/2009
-
06/2007 |
2 | Cannabinoid Receptor AgonistsIBA
01/2008
-
10/2006 |
2 | (3R)- ((2,3- dihydro- 5- methyl- 3- ((4- morpholinyl)methyl)pyrrolo- (1,2,3- de)- 1,4- benzoxazin- 6- yl)(1- naphthalenyl))methanone (WIN 55,212)IBA
01/2008
-
10/2006 |
2 | Peptide Hydrolases (Proteases)FDA Link
06/2007
-
11/2006 |
1 | Phospholipids (Phosphatides)FDA LinkGeneric
01/2021 |
1 | Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA
01/2021 |
1 | Biocompatible Materials (Biomaterials)IBA
08/2020 |
1 | Sodium Hypochlorite (Clorox)IBA
08/2020 |
1 | RNA (Ribonucleic Acid)IBA
03/2020 |
1 | Vinca AlkaloidsIBA
01/2017 |
1 | Pharmaceutical PreparationsIBA
01/2017 |
1 | capsazepineIBA
05/2014 |
1 | Cytochrome P-450 CYP2E1 (CYP2E1)IBA
09/2013 |
1 | Cytochrome P-450 CYP2C19IBA
09/2013 |
1 | Steroid 12-alpha-Hydroxylase (CYP8B1)IBA
09/2013 |
1 | human CYP2A7 protein (CYP2A7)IBA
09/2013 |
1 | Neurotransmitter Agents (Neurotransmitter)IBA
01/2013 |
1 | rat Cyp3a23-3a1 proteinIBA
10/2012 |
1 | IsoenzymesIBA
10/2012 |
1 | 6'-guanidinonaltrindoleIBA
02/2012 |
1 | norbinaltorphimineIBA
02/2012 |
1 | 4- (alpha- (4- allyl- 2,5- dimethyl- 1- piperazinyl)- 3- methoxybenzyl)- N,N- diethylbenzamideIBA
02/2012 |
1 | (trans)-Isomer 3,4- Dichloro- N- methyl- N- (2- (1- pyrrolidinyl)- cyclohexyl)- benzeneacetamideIBA
07/2011 |
1 | Opioid Receptors (Opioid Receptor)IBA
07/2011 |
1 | Ion Channels (Ion Channel)IBA
03/2011 |
1 | Anti-Bacterial Agents (Antibiotics)IBA
02/2011 |
1 | Ointments (Pastes)IBA
02/2011 |
1 | Pemetrexed (MTA)FDA Link
11/2010 |
1 | 9-hydroxyoctadecadienoic acidIBA
11/2009 |
1 | 13-hydroxy-9,11-octadecadienoic acidIBA
11/2009 |
1 | LigandsIBA
04/2009 |
1 | Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA
04/2009 |
1 | Peroxisome Proliferator-Activated Receptors (PPAR)IBA
04/2009 |
1 | PPAR alphaIBA
04/2009 |
1 | PPAR gammaIBA
04/2009 |
1 | delta Opioid Receptors (delta Opioid Receptor)IBA
01/2009 |
1 | EnkephalinsIBA
01/2009 |
1 | ProstaglandinsIBA
01/2009 |
1 | hydroxide ionIBA
11/2008 |